{"id":"https://genegraph.clinicalgenome.org/r/6a498130-d59a-4ec1-871d-649737e047b4v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *EARS2* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of September 19, 2024. *EARS2* encodes mitochondrial glutamyl-tRNA synthetase 2, one of the mitochondrial aminoacyl-tRNA synthetases, which function in mitochondrial translation by catalyzing the attachment of amino acids to their cognate tRNAs. Defects in tRNA charging can result in impaired synthesis of protein subunits of oxidative phosphorylation complexes I, III, IV, and V.\n\n*EARS2* was first reported in relation to autosomal recessive primary mitochondrial disease in 2012 (PMID: 22492562).  While various names have been given to the constellation of features seen in those with *EARS2*-related disorders (including leukoencephalopathy with thalamus and brainstem involvement and high lactate, LTBL), pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the EARS2 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *EARS2* was first curated by this Expert Panel for its association with Leigh syndrome spectrum (LSS) on February 26, 2020 (SOP V7), with a final classification of Definitive. This current curation for the association with primary mitochondrial disease includes the cases included in the LSS curation.\n \nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 17 variants (12 missense, one initiation codon, two nonsense, one frameshift, one splice) variants from 10 probands across six publications (PMIDs: 22492562, 27117034, 27206875, 27571996, 36349561, 32802952). There are additional cases reported in the medical literature; however, these were not included in this curation as the maximum genetic evidence score was reached. Affected individuals presented with a range of clinical features including LSS, developmental delay, developmental regression, seizures, ophthalmoplegia, hepatopathy, poor feeding, and lactic acidosis. Prenatal onset was reported in at least one family (PMID: 36349561). Decreased activities of mitochondrial respiratory chain enzyme complexes I, III, and IV were seen in muscle and skin fibroblasts.\n\nThis gene-disease association is also supported by the known biochemical function of *EARS2* in mitochondrial translation, functional alteration in patient cells, and rescue in patient cells (PMIDs: 22492562, 33855712). \n\nIn summary, there is definitive evidence to support the relationship between *EARS2* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 19, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/6a498130-d59a-4ec1-871d-649737e047b4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2025-01-13T14:45:57.797Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-09-19T04:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98a6a8ef-b772-40ba-ae42-73e188e8782f","type":"EvidenceLine","dc:description":"This study was scored 2 points.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88d4cda8-ce7f-4e1b-872f-4452546ef680","type":"Finding","dc:description":"Authors saw characteristic changes in more severe vs mildly affected patients (for example, levels of TCA cycle metabolites resolved almost completely upon expression of variants associated with mild phenotype but abnormalities in pathways related to nucleotide and branched-chain amino metabolism required expression of WT EARS2).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33855712","rdfs:label":"Ni_Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fc8a23f-ea8d-407f-b49e-75b2bc1954dd","type":"EvidenceLine","dc:description":"There was reduced respiratory rate and oxygen consumption in patient cell lines.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3f42edaa-a33d-4c42-8981-3884fe7e1120","type":"FunctionalAlteration","dc:description":"There was reduced respiratory rate and oxygen consumption in patient cell lines.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Patient cell biochemistry"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ffe7f2a-01af-4f6d-a7f2-affc0c0adc66","type":"EvidenceLine","dc:description":"Disorders of mitochondrial gene expression","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7dcaf7b6-fb54-4312-bf65-31a1fa23b78c","type":"Finding","dc:description":"Disorders of mitochondrial gene expression","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Disorders of mitochondrial gene expression","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/f85a9564-c49e-49f7-abd3-f3f022c9211a_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc75018d-2850-4077-aaa9-67966253d154_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d90da1f-0f98-4220-b460-defde94100cc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d90da1f-0f98-4220-b460-defde94100cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32802952","allele":{"id":"https://genegraph.clinicalgenome.org/r/adf1abbb-4875-4205-b2ac-c03aca90bbfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1488+2T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395126449"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2bcb3892-d6d0-4b8f-a94e-d2edf26e6684","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bcb3892-d6d0-4b8f-a94e-d2edf26e6684_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32802952","allele":{"id":"https://genegraph.clinicalgenome.org/r/c718662e-1c63-4c6e-af9c-382491d27f33","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1064A>G (p.Asn355Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395131414"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/cc75018d-2850-4077-aaa9-67966253d154","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32802952","rdfs:label":"Monfrini_Case","allele":[{"id":"https://genegraph.clinicalgenome.org/r/adf1abbb-4875-4205-b2ac-c03aca90bbfd"},{"id":"https://genegraph.clinicalgenome.org/r/c718662e-1c63-4c6e-af9c-382491d27f33"}],"phenotypeFreeText":"This was a man with adult onset features that included mood disorder, tremor, dysmetria, rigidity, and cognitive deterioration. Brain MRI showed extensive confluent almost symmetrical white matter abnormalities and callosal atrophy, without thalamus and brainstem involvement.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6d90da1f-0f98-4220-b460-defde94100cc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2bcb3892-d6d0-4b8f-a94e-d2edf26e6684_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/ea3fabfc-6d46-4c19-8b73-9413bf93da9a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58df015c-a231-4bcf-90ea-5c09a5edc7ae","type":"EvidenceLine","dc:description":"There is reduced oxygen consumption rate.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/58df015c-a231-4bcf-90ea-5c09a5edc7ae_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"There is reduced oxygen consumption rate.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/58df015c-a231-4bcf-90ea-5c09a5edc7ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb63a77a-37b2-4878-98e1-b47a0954d953","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1194C>G (p.Tyr398Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395129820"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/e6d4b996-d89f-4896-9e6e-1b6ee3589774","type":"EvidenceLine","dc:description":"There is reduced oxygen consumption rate.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6d4b996-d89f-4896-9e6e-1b6ee3589774_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"There is reduced oxygen consumption rate.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e6d4b996-d89f-4896-9e6e-1b6ee3589774_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.322C>T (p.Arg108Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130557"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/ea3fabfc-6d46-4c19-8b73-9413bf93da9a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Steenweg_Patient 2","allele":[{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716"},{"id":"https://genegraph.clinicalgenome.org/r/bb63a77a-37b2-4878-98e1-b47a0954d953"}],"phenotypeFreeText":"This child rresented at 5m with feeding difficulty, mild motor delay, hypotonia, unable to walk independently and had language delay. There was reduced oxygen consumption rate.\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e6d4b996-d89f-4896-9e6e-1b6ee3589774_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/58df015c-a231-4bcf-90ea-5c09a5edc7ae_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/c6b9f5c2-ca75-40b9-baae-8fc734b93349_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad6fd4a3-df8f-4aaf-a052-944483d9753d","type":"EvidenceLine","dc:description":"There was reduced oxygen consumption rate.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ad6fd4a3-df8f-4aaf-a052-944483d9753d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"There was reduced oxygen consumption rate.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ad6fd4a3-df8f-4aaf-a052-944483d9753d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/afed00c2-ced4-4fc4-8cab-a4cba6a29cbe","type":"EvidenceLine","dc:description":"There was reduced oxygen consumption rate.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/afed00c2-ced4-4fc4-8cab-a4cba6a29cbe_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"There was reduced oxygen consumption rate.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/afed00c2-ced4-4fc4-8cab-a4cba6a29cbe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/8b146e18-c37f-4bd8-b96f-19ee32c1c77c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.502A>G (p.Arg168Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2627630"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/c6b9f5c2-ca75-40b9-baae-8fc734b93349","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Steenweg_Patient 1","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8b146e18-c37f-4bd8-b96f-19ee32c1c77c"},{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716"}],"phenotypeFreeText":"This is a child with Leigh syndrome.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/afed00c2-ced4-4fc4-8cab-a4cba6a29cbe_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ad6fd4a3-df8f-4aaf-a052-944483d9753d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/16416728-96c2-493f-8f1e-1f1004dbf480_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebf9208b-bff2-41f2-97d8-f5bd03c6cb2a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ebf9208b-bff2-41f2-97d8-f5bd03c6cb2a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/79acad73-7c07-44fd-8667-7d1fd66ee5cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.320G>A (p.Arg107His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279528991"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/82d56c4b-5ddd-40d8-9b8f-69ca56d227d3","type":"EvidenceLine","dc:description":"This initiation codon variant is scored 1 point.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82d56c4b-5ddd-40d8-9b8f-69ca56d227d3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/6e123c13-4462-44b6-bec5-1d85b4ca6637","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.33A>G (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279535725"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/16416728-96c2-493f-8f1e-1f1004dbf480","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Steenweg_Patient 8","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6e123c13-4462-44b6-bec5-1d85b4ca6637"},{"id":"https://genegraph.clinicalgenome.org/r/79acad73-7c07-44fd-8667-7d1fd66ee5cb"}],"phenotypeFreeText":"This child presented at age 10m with loss of smile and speech, and also had feeding difficulties, hypotonia, seizures,  developmental delay (unable to walk without support, speech delay), progressive spasticity, and elevated blood lactate.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/82d56c4b-5ddd-40d8-9b8f-69ca56d227d3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ebf9208b-bff2-41f2-97d8-f5bd03c6cb2a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.1},{"id":"https://genegraph.clinicalgenome.org/r/d75122ed-d47c-4014-ab6e-c356dbd7b428_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8200acd-2aea-457a-a847-043fbf3b974f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8200acd-2aea-457a-a847-043fbf3b974f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27206875","allele":{"id":"https://genegraph.clinicalgenome.org/r/b069754e-cf69-4eb9-9e7a-df6b9e4ae39e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.351C>T (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395138693"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/49eef73a-e458-4c64-84c7-50195e2f49c1","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49eef73a-e458-4c64-84c7-50195e2f49c1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27206875","allele":{"id":"https://genegraph.clinicalgenome.org/r/d8f24279-189c-4f62-8745-dd135cd53954","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1546C>T (p.Arg516Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7962248"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d75122ed-d47c-4014-ab6e-c356dbd7b428","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27206875","rdfs:label":"Sahin_Case","allele":[{"id":"https://genegraph.clinicalgenome.org/r/b069754e-cf69-4eb9-9e7a-df6b9e4ae39e"},{"id":"https://genegraph.clinicalgenome.org/r/d8f24279-189c-4f62-8745-dd135cd53954"}],"phenotypeFreeText":"This child was 8m at report and presented with partial seizures at 5m, could not it unsupported. The child had elevated blood lactate and a similarly affected brother.\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d8200acd-2aea-457a-a847-043fbf3b974f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/49eef73a-e458-4c64-84c7-50195e2f49c1_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/e88be587-6577-4251-a118-7eac8d1b692f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37a9823e-24b9-4b0b-8efc-8565310c5fba","type":"EvidenceLine","dc:description":"This variant is predicted to escape NMD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/37a9823e-24b9-4b0b-8efc-8565310c5fba_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f713b2e-1a95-4197-9850-2bc7f8e594e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.51A>T (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395142807"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.25},{"id":"https://genegraph.clinicalgenome.org/r/bd1ae04d-7a95-445c-9e3c-9a679e061f5b","type":"EvidenceLine","dc:description":"There was reduced oxygen consumption.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd1ae04d-7a95-445c-9e3c-9a679e061f5b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"There was reduced oxygen consumption.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bd1ae04d-7a95-445c-9e3c-9a679e061f5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/e88be587-6577-4251-a118-7eac8d1b692f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Steenweg_Patient 10","allele":[{"id":"https://genegraph.clinicalgenome.org/r/8f713b2e-1a95-4197-9850-2bc7f8e594e8"},{"id":"https://genegraph.clinicalgenome.org/r/530d2932-02f1-41e8-b651-97f724b67716"}],"phenotypeFreeText":"This is an individual with Leigh syndrome. She was 3y at report and had developmental delay, hypotonia, regression (loss of head control, loss of smile, loss of vocalizations), made minor developmental progress, and alsoo had epilepsy, decreased vision, and elevated blood and CSF lactate. There was reduced oxygen consumption rate.\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/37a9823e-24b9-4b0b-8efc-8565310c5fba_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/bd1ae04d-7a95-445c-9e3c-9a679e061f5b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/de68bdb3-e3ed-4d6a-b24b-5267eedf52d9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/418a3ce3-afd7-4365-ba47-44b2fe4613eb","type":"EvidenceLine","dc:description":"This variant was scored as follows;  0.1 (missense) + 0.4 (decrease in abundance of mitochondrial glutamyl-tRNA synthetase protein) + 0.5 (reduced OXPHOS subunits) = 1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/418a3ce3-afd7-4365-ba47-44b2fe4613eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant was scored as follows;  0.1 (missense) + 0.4 (decrease in abundance of mitochondrial glutamyl-tRNA synthetase protein) + 0.5 (reduced OXPHOS subunits) = 1.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/418a3ce3-afd7-4365-ba47-44b2fe4613eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36349561","allele":{"id":"https://genegraph.clinicalgenome.org/r/442085ca-7979-4034-8287-e47dc3b5baf4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1465C>T (p.Arg489Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7962293"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7bdf12c4-ae3d-4a40-b98d-5e491015d545","type":"EvidenceLine","dc:description":"This variant was scored as follows;  0.1 (missense) + 0.4 (decrease in abundance of mitochondrial glutamyl-tRNA synthetase protein) + 0.5 (reduced OXPHOS subunits) = 1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7bdf12c4-ae3d-4a40-b98d-5e491015d545_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant was scored as follows;  0.1 (missense) + 0.4 (decrease in abundance of mitochondrial glutamyl-tRNA synthetase protein) + 0.5 (reduced OXPHOS subunits) = 1\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7bdf12c4-ae3d-4a40-b98d-5e491015d545_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36349561","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce29dfc3-122e-40ea-b313-ef1562a38fb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.1235G>A (p.Arg412His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7962372"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/de68bdb3-e3ed-4d6a-b24b-5267eedf52d9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36349561","rdfs:label":"Boutad_Family C","allele":[{"id":"https://genegraph.clinicalgenome.org/r/442085ca-7979-4034-8287-e47dc3b5baf4"},{"id":"https://genegraph.clinicalgenome.org/r/ce29dfc3-122e-40ea-b313-ef1562a38fb2"}],"phenotypeFreeText":"This fetus (FC1) had isolated partial posterior corpus callosum agenesis (splenium) detected at 31 weeks and terminated at 36 weeks. The fetus also had hypertelorism, broad nose, and short columella.\n\nAnother pregnancy was FC2 who had complete agenesis of the corpus callosum detected at 22 weeks and terminated at 31 weeks.","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/418a3ce3-afd7-4365-ba47-44b2fe4613eb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7bdf12c4-ae3d-4a40-b98d-5e491015d545_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/63c45d94-d97d-448e-8e2e-e1dbea0ccc51_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3608f51-4cac-48fb-b4fc-120d25056661","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3608f51-4cac-48fb-b4fc-120d25056661_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/2d0afae1-cee6-4fbd-abf8-045b42cc2417","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.500G>A (p.Cys167Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130562"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/21151c02-fb74-44b6-bc09-cdd70b2608c7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21151c02-fb74-44b6-bc09-cdd70b2608c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","allele":{"id":"https://genegraph.clinicalgenome.org/r/e5a88972-9808-4ef1-88d3-0cacbbb41ae3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001083614.2(EARS2):c.286G>A (p.Glu96Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130561"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/63c45d94-d97d-448e-8e2e-e1dbea0ccc51","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22492562","rdfs:label":"Steenweg_Patient 11","allele":[{"id":"https://genegraph.clinicalgenome.org/r/e5a88972-9808-4ef1-88d3-0cacbbb41ae3"},{"id":"https://genegraph.clinicalgenome.org/r/2d0afae1-cee6-4fbd-abf8-045b42cc2417"}],"phenotypeFreeText":"This child was 2 years old at report and had no early motor development (lack of head control, lack of fixation), was unable to walk independently, and had no language development. Overtime, the child developed epilepsy, spasticity, and required feeding tube. There was elevated blood and CSF lactate. There was also an affected sibling.\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/21151c02-fb74-44b6-bc09-cdd70b2608c7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f3608f51-4cac-48fb-b4fc-120d25056661_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/03aef170-a980-40c0-908d-3ee827576c24_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa2a65d4-9d1b-4e8e-8b07-fbb75050bf9d","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa2a65d4-9d1b-4e8e-8b07-fbb75050bf9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27117034","allele":{"id":"https://genegraph.clinicalgenome.org/r/7dd4c646-6783-410c-88b0-201b8c5b7f63","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.1445del (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA719184469"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e488bd84-7afa-4986-95ea-03268f6a7138","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e488bd84-7afa-4986-95ea-03268f6a7138_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27117034","allele":{"id":"https://genegraph.clinicalgenome.org/r/8d28d371-3b3d-479f-80d1-e58c64d49aa2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.1266C>T (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA7962373"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/03aef170-a980-40c0-908d-3ee827576c24","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27117034","rdfs:label":"Gungor_Case","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7dd4c646-6783-410c-88b0-201b8c5b7f63"},{"id":"https://genegraph.clinicalgenome.org/r/8d28d371-3b3d-479f-80d1-e58c64d49aa2"}],"phenotypeFreeText":"This child was 3y at report and had seizures, hypotonia, brisk reflexes, and elevated plasma at 7m. The child walked with support by 18m and independently by 22m.\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/aa2a65d4-9d1b-4e8e-8b07-fbb75050bf9d_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/e488bd84-7afa-4986-95ea-03268f6a7138_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/2a7f1c11-45ce-407b-a661-ebb99030a07f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73d21ead-9f6f-4d1f-95ba-ddad59bc0abf","type":"EvidenceLine","dc:description":"This initiation codon variant is scored 1 point.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73d21ead-9f6f-4d1f-95ba-ddad59bc0abf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27571996","allele":{"id":"https://genegraph.clinicalgenome.org/r/6e123c13-4462-44b6-bec5-1d85b4ca6637"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/98a32db7-0a63-4386-92c4-486b4b12220a","type":"EvidenceLine","dc:description":"Fibroblasts and muscle homogenate displayed markedly decreased EARS2 protein levels, although decreased steady-state levels of complex I (NDUFB8) and complex IV (MT-CO1 and MT-CO2) subunits were only observed in muscle.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/98a32db7-0a63-4386-92c4-486b4b12220a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fibroblasts and muscle homogenate displayed markedly decreased EARS2 protein levels, although decreased steady-state levels of complex I (NDUFB8) and complex IV (MT-CO1 and MT-CO2) subunits were only observed in muscle.\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/98a32db7-0a63-4386-92c4-486b4b12220a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27571996","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ec8e82a-d339-4f30-960f-53eab59b7789","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NR_003501.1(EARS2):n.216A>T (undefined)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA395140951"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2a7f1c11-45ce-407b-a661-ebb99030a07f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27571996","rdfs:label":"Oliveira_Case","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6e123c13-4462-44b6-bec5-1d85b4ca6637"},{"id":"https://genegraph.clinicalgenome.org/r/1ec8e82a-d339-4f30-960f-53eab59b7789"}],"phenotypeFreeText":"This is a child with hypotonia, FTT, lactic acidosis, liver dysfunction, encephalopathy, and who died at age 5m. Muscle biopsy showed COX â€“deficient fibers and RRF and decreased CI activity (19% controls) and CIV activity (11% controls).\n","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/73d21ead-9f6f-4d1f-95ba-ddad59bc0abf_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/98a32db7-0a63-4386-92c4-486b4b12220a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9791,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/rPfxWvth7wM","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:29419","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_f85a9564-c49e-49f7-abd3-f3f022c9211a-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}